The Shotlee Journal
Browse Shotlee articles about Weight Management.
Showing 9 / 869 Weight Management articles
The United States now offers an additional avenue for weight reduction as Novo Nordisk introduces its Wegovy oral medication across the country. This daily tablet, featuring semaglutide, represents the initial and sole GLP-1 pill for adults, simplifying obesity management without injections. Clinical studies indicate notable weight loss, though side effects may occur.
As January approaches, numerous individuals set New Year's resolutions focused on health and weight reduction goals. While exercise, gym visits, and nutritious diets support well-being and weight management, some may require additional help from medications. The NHS offers an important warning for those using Mounjaro injections alongside contraception or HRT.
Numerous individuals achieving weight reduction on GLP-1 agonists encounter challenges in ceasing the treatments, as appetite surges and weight rebounds. Studies indicate significant regain for those stopping, prompting some to view obesity as a chronic issue requiring ongoing medication. However, adopting healthier habits can help maintain losses post-treatment.
Many people turn to GLP-1 drugs like Ozempic for weight loss, but cost can be a barrier. Affordable alternatives like berberine offer hope, yet experts caution against unrealistic hype. This article examines its benefits, side effects, and potential as a weight loss aid.
As new health goals emerge in January, weight loss medications like Mounjaro gain popularity, but an NHS notice warns about potential interactions with birth control and hormone therapy. Estimates indicate hundreds of thousands are using these drugs privately, with guidelines stressing extra precautions for absorption issues.
A recent study reveals that GLP-1 medications can significantly decrease severe asthma episodes among adolescents who are overweight or obese. Researchers found a notable reduction in emergency room visits and steroid use. Experts suggest these drugs offer dual benefits for weight control and asthma management.
GLP-1 injectable treatments have surged in popularity in India, prompting medical professionals to emphasize comprehensive diagnostic evaluations before initiating therapy. Key assessments cover metabolic health, organ function, and specific risks to guarantee patient safety. This approach underscores the importance of medical oversight for these potent medications.
In Ohio, Representative Josh Williams is sponsoring House Bill 388 to reimburse state workers for GLP-1 medications purchased directly from manufacturers, bypassing high pharmacy costs. This initiative follows the state's decision to drop coverage in early 2025 due to expenses, with the bill proposing a more affordable reimbursement model. Williams emphasizes that this approach could slash costs while providing stable access to essential health treatments.
Shake Shack is adapting to the rise of GLP-1 medications by launching a new menu focused on protein-rich choices. The Good Fit Menu provides familiar favorites with modifications for easier, more intentional eating. This shift echoes nutritional advice and reflects broader changes in fast food.
